Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring

ConclusionsCGM use in blinded mode could be an interesting tool to reduce the risk of hypoglycemia in people with diabetes starting chemotherapy. Our findings fully support the recommendation that assessing hypoglycemia risk should be mandatory in patients with diabetes before starting chemotherapy.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research